Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

BioRestorative Therapies Q1 EPS $(0.64) Misses $(0.33) Estimate, Sales $25.00K Miss $380.00K Estimate

Author: Benzinga Newsdesk | May 14, 2025 03:06pm
BioRestorative Therapies (NASDAQ:BRTX) reported quarterly losses of $(0.64) per share which missed the analyst consensus estimate of $(0.33) by 93.94 percent. This is a 93.94 percent decrease over losses of $(0.33) per share from the same period last year. The company reported quarterly sales of $25.00 thousand which missed the analyst consensus estimate of $380.00 thousand by 93.42 percent. This is a 28.57 percent decrease over sales of $35.00 thousand the same period last year.

Posted In: BRTX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist